or Try an Advanced Search...

    Testosterone Deficiency Stocks List

    Symbol Grade Name % Change
    LLY D Eli Lilly and Company 2.03
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major
    Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Cardiovascular Products Cattle Cholesterol Depression Depressive Disorder Diabetes Dog Dysfunction Endocrinology Erectile Dysfunction

    Related ETFs - A few ETFs which own one or more of the above listed Testosterone Deficiency stocks.

    Symbol Grade Name Weight
    IHE C iShares U.S. Pharmaceutical ETF 23.01
    MEDX F Horizon Kinetics Medical ETF 14.73
    PPH C Market Vectors Pharmaceutical ETF 12.09
    IYH C iShares U.S. Healthcare ETF 11.83
    XLV C SPDR Select Sector Fund - Health Care 11.3
    View all Testosterone Deficiency ETFs...
    Compare ETFs
    Compare MEDX to IYH Compare MEDX to PPH Compare MEDX to XLV

        Testosterone Deficiency Stocks Recent News

        Date Stock Title
        May 6 LLY Investors Pile Into Amgen in Search of Next Obesity Drug Payout
        May 6 LLY 2 Top Stocks That Could Make You Richer in 2024
        May 5 LLY 3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years
        May 5 LLY 3 No-Brainer Stocks to Buy in May
        May 4 LLY Pharma R&D productivity seen improving for the first time in years - Deloitte
        May 4 LLY Eli Lilly: Great Time To Divest Before It Potentially Crashes
        May 4 LLY Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making
        May 4 LLY Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
        May 4 LLY Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
        May 3 LLY Amazon Stock Is on a Roll. Here’s Why It’s on This Firm’s ‘Best Ideas List.’
        May 3 LLY Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
        May 3 LLY Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
        May 3 LLY Analyst unveils Amgen stock price target after weight-loss drug data
        May 3 LLY Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
        May 3 LLY Weight-loss drug competition heats up. Is Wegovy in trouble?
        May 3 LLY Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
        May 3 LLY Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
        May 3 LLY US STOCKS-Wall St set to open sharply higher on soft jobs data
        May 3 LLY Amgen shares soar as executives outline obesity drug push
        May 3 LLY US STOCKS-Futures rise on Apple, Amgen boost; jobs data awaited
        Related Industries: Drug Manufacturers - Major
        Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Cardiovascular Products Cattle Cholesterol Depression Depressive Disorder Diabetes Dog Dysfunction Endocrinology Erectile Dysfunction
        Testosterone Deficiency

        Browse All Tags